Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Tiazolidinediona derivado")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 1286

  • Page / 52
Export

Selection :

  • and

ThiazolidinedionesYKI-JÄRVINEN, Hannele.The New England journal of medicine. 2004, Vol 351, Num 11, pp 1106-1118, issn 0028-4793, 13 p.Article

Sequence variation in PPARG may underlie differential response to troglitazoneWOLFORD, Johanna K; YEATTS, Kimberly A; DHANJAL, Sharanjeet K et al.Diabetes (New York, NY). 2005, Vol 54, Num 11, pp 3319-3325, issn 0012-1797, 7 p.Article

Troglitazone : the lesson that nobody learned?GALE, Edwin A. M.Diabetologia (Berlin). 2006, Vol 49, Num 1, pp 1-6, issn 0012-186X, 6 p.Article

Visfatin is an adipokine, but it is not regulated by thiazolidinedionesHAMMARSTEDT, Ann; PIHLAJAMÄKI, Jussi; SOPASAKIS, Victoria Rotter et al.The Journal of clinical endocrinology and metabolism. 2006, Vol 91, Num 3, pp 1181-1184, issn 0021-972X, 4 p.Article

MCC-555-induced NAG-1 expression is mediated in part by KLF4CEKANOVA, Maria; LEE, Seong-Ho; MCENTEE, Michael F et al.European journal of pharmacology. 2010, Vol 637, Num 1-3, pp 30-37, issn 0014-2999, 8 p.Article

Thiazolidinediones and fluid retentionKIRYLUK, K; ISOM, R.Kidney international. 2007, Vol 72, Num 6, pp 762-768, issn 0085-2538, 7 p.Article

ROSIGLITAZONE WHAT WENT WRONGCOHEN, Deborah.BMJ (Overseas and retired doctors ed.). 2010, Vol 341, Num 7772, pp 530-534, issn 1759-2151, 5 p.Article

Ineffectiveness of rosiglitazone therapy in nelson's syndromeMUNIR, A; SONG, F; INCE, P et al.The Journal of clinical endocrinology and metabolism. 2007, Vol 92, Num 5, pp 1758-1763, issn 0021-972X, 6 p.Article

Physiological Responses to Acute Psychological Stress Are Reduced by the PPARγ Agonist RosiglitazoneRYAN, Karen K; GRAYSON, Bernadette E; JONES, Kenneth R et al.Endocrinology (Philadelphia). 2012, Vol 153, Num 3, pp 1279-1287, issn 0013-7227, 9 p.Article

Rosiglitazone, marketing, and medical scienceMOYNIHAN, Ray.BMJ. British medical journal (International ed.). 2010, Vol 340, Num 7750, pp 785-788, issn 0959-8146, 4 p.Article

Thiazolidinediones increase the wingless-type MMTV integration site family (WNT) inhibitor Dickkopf-1 in adipocytes: a link with osteogenesisGUSTAFSON, B; ELIASSON, B; SMITH, U et al.Diabetologia (Berlin). 2010, Vol 53, Num 3, pp 536-540, issn 0012-186X, 5 p.Article

Ontology-based knowledge management of troglitazone-induced hepatotoxicityHUG, Hubert; DANNECKER, Robert; SCHINDLER, Richard et al.Drug discovery today. 2004, Vol 9, Num 22, pp 948-954, issn 1359-6446, 7 p.Article

Effects of troglitazone in young first-degree Relatives of patients with type 2 diabetesLEVIN, Klaus; HOTHER-NIELSEN, Ole; HENRIKSEN, Jan Erik et al.Diabetes care. 2004, Vol 27, Num 1, pp 148-154, issn 0149-5992, 7 p.Article

Progress with thiazolidinediones in the management of type 2 diabetes mellitusMERIDEN, Terry.Clinical therapeutics. 2004, Vol 26, Num 2, pp 177-190, issn 0149-2918, 14 p.Article

Thiazolidinediones: metabolic actions in vitroFÜRNSINN, C; WALDHÄUSL, W.Diabetologia (Berlin). 2002, Vol 45, Num 9, pp 1211-1223, issn 0012-186X, 13 p.Article

Stay vigilant: a glitazone (pioglitazone) can hide a glitazar!HILLAIRE-BUYS, Dominique; FAILLIE, Jean-Luc; MONTASTRUC, Jean-Louis et al.European journal of clinical pharmacology. 2012, Vol 68, Num 12, pp 1681-1683, issn 0031-6970, 3 p.Article

Pioglitazone and mechanisms of CV protectionERDMANN, E; WILCOX, R.QJM (Oxford. 1994. Print). 2010, Vol 103, Num 4, pp 213-228, issn 1460-2725, 16 p.Article

Cardiovascular Effects of Thiazolidinediones : A Review of the LiteratureACHARYA, Deepak; FALIK, Ruth.Southern medical journal (Birmingham, Ala. Print). 2009, Vol 102, Num 1, pp 51-56, issn 0038-4348, 6 p.Article

Prevention of Diabetes With Pioglitazone in ACT NOW: Physiologic CorrelatesDEFRONZO, Ralph A; TRIPATHY, Devjit; MUDALIAR, Sunder et al.Diabetes (New York, NY). 2013, Vol 62, Num 11, pp 3920-3926, issn 0012-1797, 7 p.Article

Réflexions sur « l'affaire rosiglitazone »Médecine (Montrouge). 2010, Vol 6, Num 10, pp 478-482, issn 1777-2044, 5 p.Article

Rosiglitazone Is Associated with Mortality in Chronic Hemodialysis PatientsRAMIREZ, Sylvia P. B; ALBERT, Justin M; BLAYNEY, Margaret J et al.Journal of the American Society of Nephrology. 2009, Vol 20, Num 5, pp 1094-1101, issn 1046-6673, 8 p.Article

Pyruvate Dehydrogenase Kinase 4 : Regulation by Thiazolidinediones and Implication in Glyceroneogenesis in Adipose TissueCADOUDAL, Thomas; DISTEL, Emilie; DURANT, Sylvie et al.Diabetes (New York, NY). 2008, Vol 57, Num 9, pp 2272-2279, issn 0012-1797, 8 p.Article

Clinical implications of the DREAM study. CommentaryDAVIDSON, Mayer B.Diabetes care. 2007, Vol 30, Num 2, pp 418-420, issn 0149-5992, 3 p.Article

Treatment of necrobiosis lipoidica with pioglitazoneBOYD, Alan S.Journal of the American Academy of Dermatology. 2007, Vol 57, Num 5, issn 0190-9622, S120-S121, SUPArticle

Pioglitazone is metabolised by CYP2C8 and CYP3A4 in vitro : Potential for interactions with CYP2C8 inhibitorsJAAKKOLA, Tiina; LAITILA, Jouko; NEUVONEN, Pertti J et al.Basic & clinical pharmacology & toxicology (Print). 2006, Vol 99, Num 1, pp 44-51, issn 1742-7835, 8 p.Article

  • Page / 52